Breast Neoplasm Female Clinical Trial
— mBLISS-BOfficial title:
mHealth Behavioural Intervention to Increase Breast Cancer Screening Rates Among Members of the Public
Late-stage presentation of breast cancer cases are on the rise in Malaysia. Encouraging breast screening practices can assist in early breast cancer detection. Literature has proven that behavior interventions in the form of behavior change health communication using social messaging applications is a viable strategy and potentially effective at motivating breast cancer screening among the public. Such studies are scarce in the South East Asian region, particularly in Malaysia, which is the prime motivation for the current study, Based on this promising prospect, we designed a randomized controlled trial to study the effects of applying persuasive health communication materials to initiate behavior change among a group of Malaysian women. Materials are delivered in the form of a health communication program over a social messaging application to promote breast cancer screening practices, which is either a clinical breast examination, or a mammogram. We hypothesize that Malaysian women who are exposed to such materials that are designed based on behavior science and behavior change principles will be nudged and hence more likely to attend breast cancer screening compared to a control group.
Status | Not yet recruiting |
Enrollment | 1180 |
Est. completion date | July 2025 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Female |
Age group | 40 Years and older |
Eligibility | Inclusion Criteria: 1. Malaysian women aged 40 years and above 2. Possess a smartphone with the predetermined social messaging application (derived from Phase 1 of study) installed. 3. Have not been diagnosed with cancer before. Exclusion Criteria: 1. Underwent Clinical Breast Examination in the past 12 months. 2. Mammogram screening in the past 2 years. 3. Subjects who are deemed to have cognitive impairment and unable to provide consent to the study. |
Country | Name | City | State |
---|---|---|---|
Malaysia | Institute for Clinical Research, National Institutes of Health, Malaysia | Shah Alam | Selangor |
Lead Sponsor | Collaborator |
---|---|
Clinical Research Centre, Malaysia | Institute for Health Behavioral Research, Malaysia, Ministry of Health, Malaysia, National University of Malaysia |
Malaysia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Breast cancer screening attendance (either clinical breast examination (CBE) or mammogram). | Self-reported attendance of breast cancer screening | 2 time points: 3 months after 6 month intervention period has ended, and 6 months after 6 month intervention period has ended. | |
Secondary | Health literacy level | Scored via a validated instrument | At baseline | |
Secondary | Perception based on domains in Health Belief Model | Scored via a validated revised Champion Health Belief Model Scale instrument | 3 time points: Baseline, 3 months after 6 month intervention period has ended, and 6 months after 6 month intervention period has ended. | |
Secondary | Perceived acceptance and usefulness of health communication program | Scored via a validated instrument | 3 months after 6 month intervention period has ended. | |
Secondary | Reasons behind participants not participating in breast cancer screening. | Determined via a multiple choice question | 2 time points: Baseline, and 3 months after 6 month intervention period has ended. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03980626 -
Study on Physical Activity's Relationship With Cancer and Cognition
|
N/A | |
Completed |
NCT04329819 -
Satisfaction and QUality of Life After Breast REconstruction
|
||
Recruiting |
NCT03323346 -
Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT03900884 -
Palbociclib, Letrozole & Venetoclax in ER and BCL-2 Positive Breast Cancer
|
Phase 1 | |
Completed |
NCT05042999 -
The Use of Virtual Reality During Breast Ultrasound-Guided Biopsy Procedures
|
N/A | |
Not yet recruiting |
NCT03662633 -
Diagnosis Value of SEMA4C in Breast Cancer
|
||
Recruiting |
NCT05075512 -
The Efficacy and Safety of Anlotinib Combined With Fulvestrant in Patients With Advanced Breast Cancer
|
Phase 2 | |
Recruiting |
NCT04456855 -
Locoregional Surgery of the Primary Tumor in de Novo Stage IV Breast Cancer Patients
|
||
Not yet recruiting |
NCT03629509 -
BEFORE Decision Aid Implementation Study
|
N/A | |
Completed |
NCT04811378 -
HaemoCerTM Application in Breast Cancer Surgery
|
N/A | |
Completed |
NCT03198442 -
Breast PET Feasibility
|
N/A | |
Not yet recruiting |
NCT05577442 -
Trastuzumab, Pyrotinib Combined With Dalpiciclib and Endocrine Therapy for HR +/HER2 + Advanced Breast Cancer
|
Phase 2 | |
Enrolling by invitation |
NCT04047823 -
Temperature and Injury in Radiotherapy Radiation Skin Injury
|
||
Recruiting |
NCT05452213 -
Comprehensive Analysis of Spatial, Temporal and Molecular Patterns of Ribociclib Efficacy and Resistance in Advanced Breast Cancer Patients
|
Phase 4 | |
Recruiting |
NCT05027321 -
Efficacy of Preparation in Self-Hypnosis by Anchoring Versus Conversational Hypnosis, Used Alone or Combined, in Patients Undergoing Breast Macrobiopsies
|
N/A | |
Active, not recruiting |
NCT04812652 -
Digitally Distributed Yoga for Women Treated for Breast Cancer
|
N/A | |
Active, not recruiting |
NCT03425838 -
Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
|
Phase 3 | |
Completed |
NCT05473026 -
Grateful Strides Toward Physical Activity and Well-Being for Black Breast Cancer Survivors
|
N/A | |
Completed |
NCT04509063 -
Investigating Public Enthusiasm for Mammography Screening in Denmark
|
N/A | |
Recruiting |
NCT05711030 -
Thoracic Paravertebral Block Anesthesia for Breast Cancer Surgery
|
N/A |